Safety, clinical activity, pharmacokinetics, and pharmacodynamics from a phase I study of PF-06863135, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM) Meeting Abstract
| Authors: | Raje, N. S.; Jakubowiak, A.; Gasparetto, C.; Cornell, R. F.; Krupka, H. I.; Navarro, D.; Forgie, A. J.; Udata, C.; Basu, C.; Chou, J.; Leung, A.; Lesokhin, A. M. |
| Abstract Title: | Safety, clinical activity, pharmacokinetics, and pharmacodynamics from a phase I study of PF-06863135, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM) |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160403141 |
| DOI: | 10.1182/blood-2019-121805 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1869 -- Source: Wos |
